Get free email notifications about insider trading in CYTOKINETICS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of insider trading in CYTOKINETICS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in CYTOKINETICS INC for free.

CIK Number: 0001061983
IRS Number: 943291317
Trading Symbol: CYTK

Cytokinetics, Inc. operates as a biopharmaceutical company, which focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases. It conducts a Phase 2 clinical trials program for tirasemtiv, including a Phase 2b clinical trial in patients with ALS, known as BENEFIT-ALS (Blinded Evaluation of Neuromuscular Effects and Functional Improvement with Tirasemtiv in ALS). The company was founded on August 5, 1997 and is headquartered in South San Francisco, CA.

Market Capitalization: $461.88M
Prev close: $11.70
Average Daily Volume: 312,121
Days Low: $11.30
Year Low: $6.00
Year High: $13.44

CYTOKINETICS INC Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Blum Robert IPresident & CEO224,1072,622,052shares bought: 370,000 / shares sold: -164,886 STRONG BUYJan 16 20201 month ago
BVF PARTNERS L P/IL10% Owner3,131,43236,637,754shares bought: 342,072 / shares sold: -1,072,030 STRONG SELLFeb 18 20204 days ago
Califf RobertDirector00Feb 14 20208 days ago
HENDERSON JOHN TDirector6,25073,125Feb 14 20208 days ago
Kaye Edward M. MDDirector00Feb 14 20208 days ago
Malik Fady IbrahamEVP Research & Development121,3501,419,795shares bought: 176,666 / shares sold: -70,204 STRONG BUYDec 06 20193 months ago
PARSHALL B LYNNEDirector00Feb 14 20208 days ago
SMITH SANDFORD DDirector00Feb 14 20208 days ago

View all CYTOKINETICS INC insiders.

CYTOKINETICS INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 18 2020CYTKCYTOKINETICS INCBVF PARTNERS L P/IL10% OwnerSellS15.7974,8931,182,321424,419499.3 K to 424.4 K (-15.00 %)
Feb 18 2020CYTKCYTOKINETICS INCBVF PARTNERS L P/IL10% OwnerSellS15.79510,7938,063,7872,350,8292.9 M to 2.4 M (-17.85 %)
Feb 18 2020CYTKCYTOKINETICS INCBVF PARTNERS L P/IL10% OwnerSellS15.79486,3447,677,8153,131,4323.6 M to 3.1 M (-13.44 %)
Feb 14 2020CYTKCYTOKINETICS INCSMITH SANDFORD DDirectorOption ExerciseA15.434,12463,6334,124
Feb 14 2020CYTKCYTOKINETICS INCKaye Edward M. MDDirectorOption ExerciseA15.438,248127,2678,248
Feb 14 2020CYTKCYTOKINETICS INCPARSHALL B LYNNEDirectorOption ExerciseA15.432,74942,4172,749
Feb 14 2020CYTKCYTOKINETICS INCHENDERSON JOHN TDirectorOption ExerciseA15.436,41598,9836,415
Feb 14 2020CYTKCYTOKINETICS INCCaliff RobertDirectorOption ExerciseA15.435,95791,9175,957
Jan 16 2020CYTKCYTOKINETICS INCBlum Robert IPresident & CEOSellS12.964,95064,159224,107229.1 K to 224.1 K (-2.16 %)
Jan 16 2020CYTKCYTOKINETICS INCBlum Robert IPresident & CEOSellS12.964,95064,159224,107229.1 K to 224.1 K (-2.16 %)
Jan 06 2020CYTKCYTOKINETICS INCCaliff RobertDirectorOption ExerciseA10.557587,997758
Jan 06 2020CYTKCYTOKINETICS INCHENDERSON JOHN TDirectorOption ExerciseA10.551,51716,0041,517
Jan 06 2020CYTKCYTOKINETICS INCKaye Edward M. MDDirectorOption ExerciseA10.551,51716,0041,517
Jan 06 2020CYTKCYTOKINETICS INCSMITH SANDFORD DDirectorOption ExerciseA10.557587,997758
Jan 02 2020CYTKCYTOKINETICS INCHENDERSON JOHN TDirectorBuyP8.576,00051,4276,250250 to 6.3 K (+2,400.00 %)

View all CYTOKINETICS INC insider transactions.